$9.69-6.65%
2026-10-06 close · prelimImmunityBio's published financial data is dated 2026-10-04. 2024 revenue was $15M. 2024 operating profit was −$344M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
ImmunityBio's published financial data is dated 2026-10-04. 2024 revenue was $15M. 2024 operating profit was −$344M.